Glucose and Lipid Metabolism on Antipsychotic Medication
Condition(s):Schizophrenia; Schizoaffective Disorder; Type 2 Diabetes Mellitus; HyperglycemiaLast Updated:October 2, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Schizoaffective Disorder; Type 2 Diabetes Mellitus; HyperglycemiaLast Updated:October 2, 2019Completed
Condition(s):Autism Spectrum Disorder; Conduct DisorderLast Updated:April 14, 2021Unknown status
Condition(s):Alzheimer DiseaseLast Updated:October 12, 2015Completed
Condition(s):Autism Spectrum DisorderLast Updated:September 11, 2019Completed
Condition(s):Suicide; Depressive DisordersLast Updated:August 23, 2007Terminated
Condition(s):COVID-19; Physician-Patient RelationsLast Updated:June 5, 2020Completed
Condition(s):DepressionLast Updated:December 12, 2023Completed
Condition(s):Risk Reduction BehaviorLast Updated:August 9, 2016Completed
Condition(s):SchizophreniaLast Updated:June 30, 2021Completed
Condition(s):Diabetes Mellitus; Hypertension; DyslipidemiasLast Updated:December 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.